| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
0.255 |
Evidence |
|
| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
0.255 |
Evidence |
|
| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
VPREB3 |
VPREB3, UNQ355/PRO619: Pre-B lymphocyte protein 3 precursor |
0.255 |
Evidence |
|
| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
CD83 |
CD83: CD83 antigen precursor |
0.255 |
Evidence |
|
| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.255 |
Evidence |
|
| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
0.255 |
Evidence |
|
| CD37 |
CD37, TSPAN26: Leukocyte antigen CD37 |
CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
0.255 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
MFAP5 |
MFAP5, MAGP2: Microfibrillar-associated protein 5 precursor |
0.255 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
EFEMP1 |
EFEMP1, FBLN3, FBNL: EGF-containing fibulin-like extracellular matrix protein 1 |
0.255 |
Evidence |
|
| ACR |
ACR, ACRS: Acrosin precursor |
CCIN |
CCIN: Calicin |
0.255 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
ADAM8 |
ADAM8, MS2: ADAM 8 precursor |
0.255 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
SEMA4D |
SEMA4D, CD100, SEMAJ: Semaphorin-4D precursor |
0.255 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
CLEC2B |
CLEC2B, AICL, CLECSF2, IFNRG1: C-type lectin domain family 2 member B |
0.255 |
Evidence |
|
| H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.255 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
S100A4 |
S100A4, CAPL, MTS1: Protein S100-A4 |
0.255 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
NCF2 |
NCF2: Neutrophil cytosol factor 2 |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
KLRF1 |
IPI00619913 |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
KIR2DS2 |
KIR2DS2, CD158J, NKAT5: Killer cell immunoglobulin-like receptor 2DS2 precursor |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
BTN3A2 |
BTN3A2, BT3.2, BTF3, BTF4: Butyrophilin subfamily 3 member A2 precursor |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
MYOM2 |
MYOM2: Myomesin-2 |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
KIR3DL2 |
KIR3DL2, CD158K, NKAT4: Killer cell immunoglobulin-like receptor 3DL2 precursor |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
CD96 |
CD96: T-cell surface protein tactile precursor |
0.255 |
Evidence |
|
| CD7 |
CD7: T-cell antigen CD7 precursor |
ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
0.255 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
TNFAIP6 |
TNFAIP6, TSG6: Tumor necrosis factor-inducible protein TSG-6 precursor |
0.255 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
FBN1 |
FBN1, FBN: Fibrillin-1 precursor |
0.255 |
Evidence |
|